Macrovascular Flashcards

1
Q

What four classes of anti hypertensives are preferred? In no particular order and in patients with no CV disease or CKD.

A

Thiazides
ACE
ARB
Dihydropyridine Ca blockers. Ie: amlodipine, nifedepine, felodipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

If a patient is already on an ACE and needs BP therapy intensified, what is the drug of choice?

A

CCB rather than thiazides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why should all patients with ACS be screened for diabetes prior to discharge?

A

More than 2/3 patients with an MI have diabetes or pre-diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What particular treatments for ACS are different for people with diabetes?

A

None. They should be treated the same and have the same interventions as a non-diabetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which is preferred in diabetic patients with ACS:
Clopidogrel
Ticagrelor (brillinta)
Prasugrel (Effient)

A

Undergoing PCI:
Ticagrelor or prasugrel Preference to ticagrelor as
Prasugrel only use if 65kg and no Hx of stroke.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the BP

TARGETS and Thresholds?

A

Both 130/80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why should patients with stroke be screened for diabetes?

A

Because men with D have a 2-3 fold increase and women have a 2-5 fold increase of risk of stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Is diabetes a cause of heart failure or only secondary to Ischemia?

A

Diabetes can cause HF independent of ischemic heart disease by causing diabetic cardiomyopathy that may manifest with normal or reduced left ventricular ejection fraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the recommendation ace/arb dosing and monitoring in a D patient with heart failure but Also with an eGFR less than 60?

A

Starting dose of ACE/ARB should be HALVED

Within 7-10 days of initiation or titration of therapy, monitor:
Electrolytes, eGFR, BP, weight and heart failure sx and signs.

Dose up more gradually but target same doses as non diabetics even B Blockers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

People with diabetes have a CV age _____ years in advance of their chronological age.

A

10-15 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Reduced life expectancy is __ years due to CVD.

A

12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ASA for primary prevention?

A

No reduction of CAD events but increase in bleeding.

MAY be considered if high risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

At what age should an ACE or ARB be started if signs of microv

A

Age 55

OR younger if clinical macrovascular disease or microvascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When should a statin be initiated? 4

A

Age > 40

Age > 30 if diabetes > 15 years.

Microvascular complications

Framingham high risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The presence of CAD in type one pts is related to:

A
Age
Duration of D 
Higher A1C 
Higher albumin excretion 
Traditional factors (smoking, weight, total and LDL cholesterol)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Are type 1 diabetics at higher CAD risk than people without D?

A

Type 1 D is an independent risk factor for premature CV disease and MORTALItY in young adults (20-39)

17
Q

In secondary prevention, what if ASA cannot be tolerated?

A

Clopidogrel cAn be used

18
Q

What is the most common lipid panel seen when a type 2 is tested?
ALSO, What’s the difference in LDL particles in non-D people and D people?

A

High TG
Low HDL
Normal LDL-C

Note:the atherogenicity of LDL is increased in D due to glucagon and oxidation!!

LDL particles are smaller and denser

19
Q

If a patient cannot fast for a lipid panel, what markers can be used which are NOT affected by fasting?

A

Non HDL cholesterol

Apo-B

20
Q

How often should a lipid panel be done in all patients with D?

A

Upon dx
Then yearly or as clinically indicated.
OR every 3-6 months if treatment is initiated.

21
Q

Which pts are automatically high risk Framingham, Ie: >= 20%

A

Age > 40
Age > 30 if D more than 15 years
Microvascular disease.

Clinical vascular disease
Abdominal aortic aneurysm
CKD
High risk HTN

22
Q

Low risk Framingham is at what percent?

A

Less than 10%

23
Q

When should a baseline ECG be done?

How often should it be repeated?

A

Age > 40
Age greater than 30 if D more than 15 years
Cardiac risk factors such as HTN, proteinuria, reduced pulses or vascular Bruits (sound heard in artery due to narrowing)
Microvascular or macrovascular damage

Every 2 years!

24
Q

What is the initial test for investigation of CAD if indicated ?

A

Exercise ECG stress testing.

25
Is IFG or IGT more closely associated with CVD outcomes?
IGT
26
When should fibrates and statins for sure not be used together?
CKD. Increased risk of rhabdo
27
Which statins need lower doses in eGFR less than 60?
Atorv | Prava
28
Who should have a stress test done?
``` Typical or atypical cardiac symptoms. PAD Carotid Bruits TIA stroke Resting ECG abnormalities. ```
29
What if a patient CANNOT do an exercise ECG test or if there's resting ECG abnormalities?
Do pharmacilogic stress echo or nuclear imaging
30
If a patient is on Max statin and still has low HDL AND LDL Is not at target, what should you add?
Can add niacin.
31
If a patient is on Max statin and still LDL Is not at target, what should you add?
Can add ezetrol, fibtraye or niacin.
32
When should non HDL-C be used? | What's the target?
If patient cannot fast. Should be less than 2.6
33
Resting ECG should be repeated every 3-5 years in what individuals?
Age > 40 Duration of diabetes >15 yrs and older than age 35 End organ danage One or more CVD risk factor Age >40 and planning to undertake very vigorous or prolonged exercise.
34
What is the Apolipiprtein B target? | What is the non-HDL cholesterol goal?
0.8 | <2.6
35
After initial lipid profile screening is done, hiw often do you retest for 1- patient started on statin 2- patirnt not started on statin
1- wvery 3 to 6 months to verify targets being met | 2- wvery 1-3 years depending on risk
36
What drug do you start if TG >10 and need to reduce risk of pancreatitis
Fibrate
37
Albuminuria is an indeoendant risk factir for HF. Increased ACR gives a pt an ____ x increase in Risk of developong HF AND how can we lower the risk with drugs?
2-4 x | RAAS blockade
38
Do HF patinets with D need to be treated differently than HF pts without D?
No. Same deugs. Eg. Ivabradine is effective regardleas.